// company-profile

OnKure Therapeutics, Inc.

OKUR
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings70Insiders29
// api This OnKure Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Mathers Edward T.

// 90-day insight

Over the last 90 days, OnKure Therapeutics, Inc. insiders bought $0 across 11 transactions with no open-market sales.

  • Most active insider: Ratcliffe Liam with 2 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of OnKure Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$113.5M
QoQ change
+258.2%
Reporting period
2026-03-31
#1
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$16.6M
4.0M shares
#2
ACORN CAPITAL ADVISORS, LLC
CIK 2054410
$11.8M
2.8M shares
#3
StepStone Group LP
CIK 1502287
$11.0M
2.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 4, 2026Mathers Edward TOKUR
Award
7,650$0.00$0K
Jun 4, 2026Phillips Andrew JohnOKUR
Award
7,650$0.00$0K
Jun 4, 2026Jansen Valerie MalyvanhOKUR
Award
7,650$0.00$0K
Jun 4, 2026Carruthers R MichaelOKUR
Award
7,650$0.00$0K
Jun 4, 2026Ratcliffe LiamOKUR
Award
1,275$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.